Cargando…
Stimulation of cannabinoid receptor 2 (CB(2)) suppresses microglial activation
BACKGROUND: Activated microglial cells have been implicated in a number of neurodegenerative disorders, including Alzheimer's disease (AD), multiple sclerosis (MS), and HIV dementia. It is well known that inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines play an import...
Autores principales: | Ehrhart, Jared, Obregon, Demian, Mori, Takashi, Hou, Huayan, Sun, Nan, Bai, Yun, Klein, Thomas, Fernandez, Francisco, Tan, Jun, Shytle, R Douglas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1352348/ https://www.ncbi.nlm.nih.gov/pubmed/16343349 http://dx.doi.org/10.1186/1742-2094-2-29 |
Ejemplares similares
-
Microglial Cannabinoid CB(2) Receptors in Pain Modulation
por: Xu, Kangtai, et al.
Publicado: (2023) -
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
por: Giunta, Brian, et al.
Publicado: (2011) -
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2009) -
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2008) -
Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)